ClinicalTrials.gg
Not yet recruitingNCT06269471SSICCUpdated Feb 21, 2024

On the ICC's Path: a Prevalence Study

An observational study in Chronic Ankle Instability, sponsored by University Hospital, Grenoble. Not yet recruiting at 1 site in France. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-02-21.

Sponsored by University Hospital, Grenoble · Observational

How we know

From the registry’s dates

  • Primary completion was expected by May 2024, 2 years 5 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
385
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 24 studies in Ankle Injuries with a site in France — 6 open to participants now, 7 under way, none of them phase 3. Ankle Injuries · France.

Planned enrollment
2nd of 13
385 · median 82
Started
2024
with 3 others
Observational
13 of 24
3 open now
Registered
15th of 24
by date
Lead sponsor
2 of 24
University Hospital, Grenoble

Among the 24 studies in Ankle Injuries with a site in France, this one is the 2nd largest by planned enrollment of the 13 observational ones that give a count, is one of 4 that started in 2024, is one of 13 observational ones, and was the 15th registered.

Ankle Injuries

354 studies on the registry are indexed under Ankle Injuries; 77 are open to participants now.

Browse Ankle Injuries studies →

Open to participants now

6 of the 24 studies in Ankle Injuries with a site in France are open now. Recruiting first, the newest first:

All 6 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 47 Ankle Injuries studies recruiting now, 11 (23%) set no upper age limit and 33 (70%) stop at 75 or younger; 10 take children under 18; 8 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 24 studies in Ankle Injuries with a site in France, or all of them as a file.
02

Study summary

The number of trailers is growing all the time, and TRu seems to be a risky activity for the ankle joint. Ankle sprains can lead to significant health consequences, as in the case of chronic ankle instability.

However, there are no studies informing of the prevalence of chronic ankle instability in trail running. The aim of this study is therefore to take stock of chronic ankle instability in trail running in France.

Read the detailed description

Trail Running Trail running (TRu) is a running sport that abounds in creativity in the composition of its courses. It is the most popular sport in off-road running. The International Trail Running Association (ITRA), TRu's international governing body since 2013, with the International Association of Ultrarunners (IAU), manages and develops ultra-distance races under the patronage of the International Association of Athletics Federations (IAAF). They defines TRu as running in a natural environment including mountains, deserts, forests, coastal areas, jungles or rainforests, grassy or arid plains over a variety of different terrains with a minimum of paved or asphalt roads (not exceeding 20 to 25% of the total course). TRu can be practiced in competitions open to all, in semi-self-sufficiency or in self-sufficiency. The latter takes place with respect for sporting ethics, fairness, solidarity and the environment. This sport differs from Ultra Trail Running in terms of distance. Indeed, any race longer than a marathon, i.e. 42.195km, qualifies as an Ultra. On the other hand, there is no difference or restriction as to the altitude difference covered.

According to the Fédération Française d'Athlétisme (FFA), there are now over 800,000 TRu enthusiasts in France and 20 million worldwide. For more than ten years, this outdoor sport, whose popularity grew with the Covid-19 pandemic, has been growing at an annual rate of around 12% worldwide. The year 2022, for example, saw a massive expansion, with more Trail Running events than road races recorded in France for the first time (3035 versus 2706). This represents an average of almost 418 events scheduled every weekend for TRu enthusiasts.

Ankle sprains Among the most common sports pathologies, lateral ankle sprains are the most common, well ahead of muscle injuries and tendinopathies. In 2015 in France, there were nearly 6,000 cases of ankle sprains every day, corresponding to more than 1.2 million euros in just 24 hours. In other words, 70% of the population has already suffered a sprain in the course of their life. These figures reflect a real public health problem.

Ankle sprain is described as a "condition resulting from distortion beyond physiological limits during forced, abrupt movement of the hindfoot without permanent bony displacement". Four different types of ankle sprains are usually reported, including lateral talocrural sprain (the most common), medial talocrural sprain (extremely rare), subtalar sprain and anterior sprain. In 95% of cases, the injury involves the lateral collateral ligament plane. The patho-mechanics of this injury correspond to a sequence of forced inversion associated with pure varus, internal rotation, forced plantar flexion, and forced eversion.

Chronic ankle instability Ankle sprains have the highest recurrence rate of all lower-limb injuries, and in 40% of cases develop into chronic instability. Following a first episode, 70% of people will suffer a recurrence. In fact, this risk doubles the following year. Poor management of ankle sprains can have significant consequences for the joint and its function.

According to the new model updated by Hertel, chronic ankle instability (CAI) is defined by 8 elements. These include the sprain and associated primary tissue damage, environmental factors, personal factors, patho-mechanical impairments, perceptual and sensory impairments, behavioral and motor impairments, the interactions between each element and the spectrum of clinical outcomes. A patient with CHF, however, does not systematically possess each of these impairments.

Copers patients The mere presence of an ankle sprain does not determine the evolution of this injury into chronic instability. Indeed, so-called "Copers" patients have suffered a lateral ankle sprain but have not developed a sensation of instability or sprain recurrence after 12 months. The explanations for this recovery are multiple and specific to each patient.

The Cumberland Ankle Instability Tool Several diagnostic tools can be used to assess CCI. The International Ankle Consortium recommends the use of the Cumberland Ankle Instability Tool as a validation questionnaire specific to chronic ankle instability. The CAIT consists of 9 items in a 30-point format to measure the severity of functional ankle instability (FAI). This validated self-questionnaire distinguishes between people with CAI and those without (p\<0.001), with a threshold score ≤ 23 points for the French version and ≤ 25 for the English version. Significant correlations were observed between the CAIT, the LEFS and the VAS, other validated questionnaires, in addition to excellent test-retest reliability. The translation of this self-questionnaire involves different threshold scores (≤23 and ≤25) respectively validated.

Data on ankle sprain and TRu PubMed lists over 2,234 results for the keyword "ankle chronic instability". A search for the keywords "ankle chronic instability" AND "sport", reveals 503 corresponding studies, i.e. 4 times fewer. A search of "ankle chronic instability" AND "running", reveals almost 48 results. Despite this, the new combination of "ankle chronic instability" AND "trail running" yields no published studies. The terms "outdoor", "mountain", "ultra trail running" or "hiking" also produced no results.

Given the increase in practice and the lack of data, further research is paramount knowledge about chronic ankle instability in TRu. There are good reasons to believe that ankle injuries are frequent in this sport and that they can have significant consequences.

Objectives As a first step, investigators will study the prevalence of CCI among TRu practitioners. Prevalence, which corresponds to the number of cases of a disease in a population at a given time, encompassing both new and old cases, would enable us to assess the relevance or otherwise of conducting further, more in-depth studies on the subject. Investigators would also like to clarify the circumstances and factors associated with the injury, in order to establish a true picture of this pathology in France.

Issues In summary, the number of runners is constantly increasing, and TRu seems to be a high-risk activity for the ankle joint. Ankle sprains can lead to significant health consequences, as in the case of chronic ankle instability.

However, there are no studies on the prevalence of chronic ankle instability in trail running. The aim of this study is, therefore, to take stock of chronic ankle instability in trail running in France.

03

Conditions studied

  • Chronic Ankle Instability

Browse trials for

Keywords

  • Chronic Ankle Instability
  • Trail Running
  • Ultra Trail Running
  • Ankle Sprain
  • Prevalence
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Adult Trail Running racers who have participated in at least one Trail Running competition in their lifetime. Subjects will be recruited via an online questionnaire distributed through various French Trail Running organizations and social networks.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Trail Running
  • Ultra Trail Running runners
  • Having participated́ in at least one Trail Running or Ultra Trail Running competition in their lifetime.
  • Over 18 years of age (adult participants)

Exclusion criteria

Exclusion Criteria:

  • Adults protected under Article L1121-8 of the French Public Health Code
  • Minors
  • Adults unable to give consent
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
385 participants (estimated)
Patient registry
No

Groups and cohorts

  • Trailers

    Group of major trail runners who have already taken part in at least one trail running competition in their lives.

06

What researchers measure

Primary outcomes

  1. Prevalence of chronic ankle instability in trailers

    Number of cases among all respondents with a Cumberland Ankle Instability Tool Score ≤ 23 points for the French version end ≤ 25 points for the English version. (validated questionnaire)

    Time frame: Time 0

Secondary outcomes

  1. Socio-demographic data (1/4)

    Average ages among the 3 study populations (in years)

    Time frame: Time 0

  2. Socio-demographic data (2/4)

    Proportion of sex ratios among 3 study populations

    Time frame: Time 0

  3. Socio-demographic data (3/4)

    Proportion of majority training grounds among 3 study populations

    Time frame: Time 0

  4. Socio-demographic data (4/4)

    Proportion of practice statuses among the 3 study populations

    Time frame: Time 0

  5. Trail running and prevalence reports (1/11)

    Proportion of training club members among the 3 populations studied

    Time frame: Time 0

  6. Trail running and prevalence reports (2/11)

    Average years of practice among the 3 populations studied (in years)

    Time frame: Time 0

  7. Trail running and prevalence reports (3/11)

    Average training hours per week among the 3 populations studied (in hours)

    Time frame: Time 0

  8. Trail running and prevalence reports (4/11)

    Average distances covered in training per week among the 3 populations studied (in kilometers)

    Time frame: Time 0

  9. Trail running and prevalence reports (5/11)

    Proportion of competitions per year among the 3 populations studied

    Time frame: Time 0

  10. Trail running and prevalence reports (6/11)

    Average distances covered in competition among the 3 study populations (in kilometers)

    Time frame: Time 0

  11. Trail running and prevalence reports (7/11)

    Average times spent in competition among the 3 populations studied (in hours)

    Time frame: Time 0

  12. Trail running and prevalence reports (8/11)

    Proportions of sprain occurrence times during annual programming among Copers and ICC populations

    Time frame: Time 0

  13. Trail running and prevalence reports (9/11)

    Proportion of sprain occurrence times during sessions among Copers and ICC populations

    Time frame: Time 0

  14. Trail running and prevalence reports (10/11)

    Proportions of sprain occurrence times according to pitch inclination variability in the Copers and ICC populations.

    Time frame: Time 0

  15. Trail running and prevalence reports (11/11)

    Proportion of sprain occurrence times according to variability of terrain characteristics in the Copers and ICC populations.

    Time frame: Time 0

  16. Associated pathologies (1/2)

    Proportions of the presence or absence of musculoskeletal disorders recorded over the past 12 months among the 3 populations studied.

    Time frame: Time 0

  17. Associated pathologies (2/2)

    Proportions and body chart of pathologies among participants having recorded a musculoskeletal disorder in the last 12 months within the 3 populations studied

    Time frame: Time 0

  18. Medical care (1/3)

    Proportion of participants having had or using physiotherapy in the Copers and ICC populations.

    Time frame: Time 0

  19. Medical care (2/3)

    Proportions of medical devices used among Copers and ICC populations

    Time frame: Time 0

  20. Medical care (3/3)

    Proportion of different sprain-related impacts among Copers and ICC populations

    Time frame: Time 0

07

Study locations

1 site
  • University Grenoble Alpes
    Grenoble, 38000, France
    • Leo Druart · Contactleo.druart@univ-grenoble-alpes.fr
    • Audrey Milon · Principal investigator
    • Massamba M'Baye · Sub investigator
    • Thomas Lathière · Sub investigator
    • Maïa Dolopogoloff · Sub investigator
    • Guillaume Néron · Sub investigator
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Mar 2024; primary completion for May 2024, 2 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 4, 2023
First posted
Feb 21, 2024
StartEst.
Mar 1, 2024
Primary completionEst.
May 30, 2024
CompletionEst.
Jul 30, 2024
Last update
Feb 21, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 21, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06269471
Responsible party
Sponsor
First posted
Feb 21, 2024
Start date
Mar 1, 2024 (estimated)
Primary completion
May 30, 2024 (estimated)
Completion
Jul 30, 2024 (estimated)
Last update
Feb 21, 2024

Study contacts

Aïda Mandzo
Contact
amandzo@chu-grenoble.fr
+33 (0)4 76 76 68 16
Leo Druart, PhD
principal investigator · University Grenoble Alpes

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion